Erratum: Enantioselective total synthesis of a novel polyketide natural product (+)-integrasone, an HIV-1 integrase inhibitor (Chemical Communications (2005) 3210-3212) (10.1039/b502024g);Enantioselective total synthesis of a novel polyketide natural product (+)-integrasone, an HIV-1 integrase inhibitor

Chemical Communications

Volumn , Issue 25, 2005, Pages 3210-3212

  Mehta, Goverdhan ^a   Roy, Subhrangsu ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BENZOQUINONE; ANTIRETROVIRUS AGENT; CYCLOPENTADIENE DERIVATIVE; INTEGRASE; INTEGRASE INHIBITOR; INTEGRASONE; INTEGRIC ACID; L 870812; NATURAL PRODUCT; POLYKETIDE; UNCLASSIFIED DRUG; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DIELS ALDER REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOSELECTIVITY; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY;

EID: 22344456500     PISSN: 13597345     EISSN: None     Source Type: Journal    
DOI: 10.1039/b502024g     Document Type: Erratum

References (23)

1. H. Fan, R. F. Conner and L. P. Villarreal, Biology of AIDS, (4th edition), 2000, Jones and Bartlett Publishers, Sudbury MA.
2. D. D. Richman, Science, 1996, 272, 1886.
3. (a) F. Rodriguez-Barrios and F. Gago, Curr. Top. Med. Chem., 2004, 4, 991;
4. (b) S. J. Little, S. Holte, J.-P. Routy, S. E. Daar, M. Markowitz, C. A. Collier, A. R. Koup, W. J. Mellors, E. Connick, B. Conway, M. Kilby, L. Wang, M. J. Whitcomb, S. N. Hellman and D. D. Richman, N. Engl J. Med, 2002, 347, 385.
5. R. Craigle, J. Biol. Chem., 2001, 276, 23213.
6. D. J. Hazuda, P. Felock, M. Witmer, A. Wolfe, K. Stillmock, J. A. Grobler, A. Espeseth, L. Gabryeliski, W. Schleif, C. Blau and M. D. Miller, Science, 2000, 287, 616.
7. D. J. Hazuda, S. D. Young, J. P. Guare, N. J. Anthony, R. P. Gomez, J. S. Wai, J. P. Vacca, L. Handt, S. L. Motzel, H. J. Klein, G. Dornadula, R. M. Danovich, M. Witmer, K. A. A. Wilson, L. Tussey, W. Schleif, L. Gabryeliski, L. Jin, M. D. Miller, D. R. Casimiro, E. A. Emini and J. W. Shiver, Science, 2004, 305, 528.
8. (a) S. B. Singh, D. Zink, J. Polishook, D. Valentine, A. Shafiee, K. Silverman, P. Felock, A. Teran, D. Vilella, D. J. Hazuda and R. P. Lingham, Tetrahedron Lett., 1999, 40, 8775;
9. (b) S. B. Singh, P. Felock and D. J. Hazuda, Bioorg. Med. Chem. Lett, 2000, 10, 235.
10. K. B. Herath, H. Jayasuriya, G. F. Bills, J. D. Polishook, A. W. Dombrowski, Z. Guan, P. Felock, D. J. Hazuda and S. B. Singh, J. Nat. Prod, 2004, 67, 872.
11. (a) G. Mehta and K. Islam, Tetrahedron Lett., 2003, 44, 3569;
12. (b) G. Mehta and S. S. Ramesh, Tetrahedron Lett., 2004, 45, 1985;
13. (c) G. Mehta and K. Islam, Org. Lett., 2004, 6, 807;
14. G. Mehta and S. C. Pan, Org. Lett., 2004, 6, 811;
15. (d) G. Mehta and K. Islam, Tetrahedron Lett., 2004, 45, 3611;
16. (d) G. Mehta and S. Roy, Org. Lett, 2004, 6, 2389;
17. G. Mehta and S. C. Pan, Org. Lett., 2004, 6, 3985.
18. For a recent review on epoxyquinol natural product synthesis, see: J. Marco-Contelles, M. T. Molina and S. Anjum, Chem. Rev., 2004, 104, 2857.
19. 13C NMR, and HRMS). For the spectral data and copies of spectra of selected compounds, see Supplementary Information.
20. A. Rodríguez, M. Nomen, B. W. Spur and J. J. Godfroid, Tetrahedron Lett., 1999, 40, 5161.
21. Efforts were made to optimize the yield of the required product (-)-12 by varying the temperature and solvent. At lower temperature (<-10 °C) the reaction was sluggish, while at higher temperature (∼0 °C) more of the reduction product 14 was formed.
22. M. Zhao, J. Li, E. Mano, Z. Song, D. N. Tschaen, E. J. J. Grabowski and P. J. Rider, J. Org. Chem., 1999, 64, 2564.
23. An alternate possibility of formation of (+)-3 from 15 via the intermediacy of a lactol cannot be ruled out.